Grant: Doctoral: Vanier Canada Graduate Scholarships
McGill University
$150,000.00
The Invisible Son: Understanding the factors that influence parents' HPV vaccine decision-making for their sons
FY 2013-14
Summary
The human papillomavirus (HPV) is the most common sexually transmitted infection. HPV is the primary cause of cervical cancer. HPV causes an estimated 90% of anal, 40% of penile, and 12% of oral cancers. In both men and women, HPV can also cause genital warts. Health Canada has approved and recommended a safe and effective HPV vaccine for both males and females aged 9-26 years. In Canada, publicly funded school-based HPV vaccine programs are currently available to girls aged 9-13 years. Some provinces offer catch-up programs for girls up to 18 years old. Across Canada, HPV vaccination rates among females vary and are often too low to protect the entire population. We do not know HPV vaccine uptake rates in Canadian boys. Parents of boys who wish to obtain the vaccine must assume the cost (approximately $300-400 for 3 doses). Therefore, parents must evaluate many factors (e.g.,benefits vs. costs, sesocial influences) before deciding whether or not to vaccinate their sons. We are interested in what parents know about HPV and the HPV vaccine, their attitudes towards the vaccine and which factors influence their decision-making process. First, we will conduct a random Canada-wide online survey of 3500 parents of boys (aged 9-16) to assess knowledge, attitudes and beliefs about the HPV vaccine. Parents will be grouped according to their stage of adoption in the decision-making process. Second, we will conduct a follow-up study 6 months later to assess whether parents' vaccination decision stage has changed and which factors influenced these changes. This survey data will provide us with a recent estimate of HPV vaccine uptake rates in young Canadian males. This is one of the first studies that aims to identify the key factors that influence changes in parents' HPV vaccine decisions over time. The results of this study will better inform public health strategies and the development of educational interventions (e.g.pamphlets, videos) to prevent HPV and HPV-related cancer
Department
Program
Doctoral: Vanier Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
299877
Name
Perez Samara
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
The Invisible Son: Understanding the factors that influence parents' HPV vaccine decision-making for their sons
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Cancer; Cancer Prevention; Determinants Of Health; Health Decision-Making; Hpv Vaccine; Human Papillomavirus (Hpv); Immunization Attitudes And Beliefs; Psychosocial Factors; Psychosocial Oncology; Vaccine Decision-Making
Abstract
The human papillomavirus (HPV) is the most common sexually transmitted infection. HPV is the primary cause of cervical cancer. HPV causes an estimated 90% of anal, 40% of penile, and 12% of oral cancers. In both men and women, HPV can also cause genital warts. Health Canada has approved and recommended a safe and effective HPV vaccine for both males and females aged 9-26 years. In Canada, publicly funded school-based HPV vaccine programs are currently available to girls aged 9-13 years. Some provinces offer catch-up programs for girls up to 18 years old. Across Canada, HPV vaccination rates among females vary and are often too low to protect the entire population. We do not know HPV vaccine uptake rates in Canadian boys. Parents of boys who wish to obtain the vaccine must assume the cost (approximately $300-400 for 3 doses). Therefore, parents must evaluate many factors (e.g.,benefits vs. costs, sesocial influences) before deciding whether or not to vaccinate their sons. We are interested in what parents know about HPV and the HPV vaccine, their attitudes towards the vaccine and which factors influence their decision-making process. First, we will conduct a random Canada-wide online survey of 3500 parents of boys (aged 9-16) to assess knowledge, attitudes and beliefs about the HPV vaccine. Parents will be grouped according to their stage of adoption in the decision-making process. Second, we will conduct a follow-up study 6 months later to assess whether parents' vaccination decision stage has changed and which factors influenced these changes. This survey data will provide us with a recent estimate of HPV vaccine uptake rates in young Canadian males. This is one of the first studies that aims to identify the key factors that influence changes in parents' HPV vaccine decisions over time. The results of this study will better inform public health strategies and the development of educational interventions (e.g.pamphlets, videos) to prevent HPV and HPV-related cancer
Competitiondate
201311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Perez, Samara
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~